Cardio Vascular

  • Sentobiox 62.5 & 125

    Sentobiox®

    Bosentan is indicated for Pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability and to decrease clinical worsening, and Systemic sclerosis with ongoing digital ulcer disease. Sentobiox is indicated for Hypertension and Chronic thromboembolic pulmonary hypertension, as well.

  • Biosugrel

    Biosugrel®

    Prasugrel: Reduces rate of thrombotic cardiovascular events (eg, stent thrombosis) in patients with unstable angina

  • Biolozax h

    Biolozax-H®

    Losartan / Hydrochlorothiazide: Biolozax-H is indicated for the treatment of hypertension.Biolozax-H is indicated to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy.

  • Biotor plus

    Biotor plus®

    Amlodipine / Atorvastatin: Biotor plus is a combination of two drugs, Amlodipine (antihypertensive/antianginal agent) and an Atorvastatin (cholesterol lowering agent)  and is indicated in patients for whom treatment with both Amlodipine and Atorvastatin is appropriate

Copyright © 2017 Bakhtar Bioshimi Co, All rights reserved.